These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 25808102)

  • 1. Unbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathy.
    Kubli DA; Gustafsson ÅB
    Antioxid Redox Signal; 2015 Jun; 22(17):1527-44. PubMed ID: 25808102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy and mitophagy in diabetic cardiomyopathy.
    Kobayashi S; Liang Q
    Biochim Biophys Acta; 2015 Feb; 1852(2):252-61. PubMed ID: 24882754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.
    Schilling JD
    Antioxid Redox Signal; 2015 Jun; 22(17):1515-26. PubMed ID: 25761843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
    Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
    J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial redox status, mitophagy and cardioprotection: a potential way to amend diabetic heart?
    Bai T; Wang F; Zheng Y; Liang Q; Wang Y; Kong J; Cai L
    Clin Sci (Lond); 2016 Sep; 130(17):1511-21. PubMed ID: 27433024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy.
    Westermeier F; Navarro-Marquez M; López-Crisosto C; Bravo-Sagua R; Quiroga C; Bustamante M; Verdejo HE; Zalaquett R; Ibacache M; Parra V; Castro PF; Rothermel BA; Hill JA; Lavandero S
    Biochim Biophys Acta; 2015 May; 1853(5):1113-8. PubMed ID: 25686534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets.
    Sung MM; Hamza SM; Dyck JR
    Antioxid Redox Signal; 2015 Jun; 22(17):1606-30. PubMed ID: 25808033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes.
    Xu X; Kobayashi S; Chen K; Timm D; Volden P; Huang Y; Gulick J; Yue Z; Robbins J; Epstein PN; Liang Q
    J Biol Chem; 2013 Jun; 288(25):18077-92. PubMed ID: 23658055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mst1 inhibits Sirt3 expression and contributes to diabetic cardiomyopathy through inhibiting Parkin-dependent mitophagy.
    Wang S; Zhao Z; Fan Y; Zhang M; Feng X; Lin J; Hu J; Cheng Z; Sun C; Liu T; Xiong Z; Yang Z; Wang H; Sun D
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1905-1914. PubMed ID: 29674007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between autophagy and apoptosis in the diabetic heart.
    Ouyang C; You J; Xie Z
    J Mol Cell Cardiol; 2014 Jun; 71():71-80. PubMed ID: 24513079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments.
    Zhi F; Zhang Q; Liu L; Chang X; Xu H
    Cell Stress Chaperones; 2023 Nov; 28(6):641-655. PubMed ID: 37405612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dynamics in diabetic cardiomyopathy.
    Galloway CA; Yoon Y
    Antioxid Redox Signal; 2015 Jun; 22(17):1545-62. PubMed ID: 25738230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy and Mitochondria in Obesity and Type 2 Diabetes.
    Sarparanta J; García-Macia M; Singh R
    Curr Diabetes Rev; 2017; 13(4):352-369. PubMed ID: 26900135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction in diabetic cardiomyopathy.
    Duncan JG
    Biochim Biophys Acta; 2011 Jul; 1813(7):1351-9. PubMed ID: 21256163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
    Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
    J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options.
    Cieluch A; Uruska A; Zozulinska-Ziolkiewicz D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How exercise may amend metabolic disturbances in diabetic cardiomyopathy.
    Hafstad AD; Boardman N; Aasum E
    Antioxid Redox Signal; 2015 Jun; 22(17):1587-605. PubMed ID: 25738326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy in the diabetic heart: A potential pharmacotherapeutic target in diabetic cardiomyopathy.
    Dewanjee S; Vallamkondu J; Kalra RS; John A; Reddy PH; Kandimalla R
    Ageing Res Rev; 2021 Jul; 68():101338. PubMed ID: 33838320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.
    Varga ZV; Giricz Z; Liaudet L; Haskó G; Ferdinandy P; Pacher P
    Biochim Biophys Acta; 2015 Feb; 1852(2):232-42. PubMed ID: 24997452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial autophagic energy stress responses--macroautophagy, mitophagy, and glycophagy.
    Delbridge LM; Mellor KM; Taylor DJ; Gottlieb RA
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1194-204. PubMed ID: 25747748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.